비교리스트

 카트 문의
시장보고서
상품코드
1450848

골관절염 치료 - 시장 규모 및 예측, 세계 및 지역별 점유율, 동향 및 성장 기회 분석 보고서 : 치료 유형별, 적응증별, 최종 사용자별, 지역별

Osteoarthritis Therapy Market Size and Forecasts, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type, Disease Indication, End User, and Geography
발행일: | 리서치사: The Insight Partners | 페이지 정보: 영문 199 Pages | 배송안내 : 즉시배송

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

골관절염 치료제 시장 규모는 2022년 173억 6,000만 달러에서 2030년 306억 8,000만 달러에 달하고, 2022-2030년 7.4%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다. 골관절염 유병률 증가와 약물 의존도를 낮추는 혁신적인 치료 옵션은 골관절염 치료 시장을 이끄는 주요 요인입니다. 그러나 제품 회수가 골관절염 치료제 시장의 성장을 저해하는 요인으로 작용하고 있습니다. 또한, 골관절염 치료를 촉진하는 보다 효과적인 치료 옵션은 예측 기간 동안 유리한 시장 동향으로 작용할 것입니다.

성장 촉진요인

골관절염 유병률 증가가 골관절염 치료제 시장 성장을 주도하고 있습니다.

CDC 보고서에 따르면, 전 세계적으로 5억 명 이상이 OA로 고통받고 있으며, 이는 전 세계 인구의 7%를 차지합니다. 장기 장애의 주요 원인이 되고 있습니다. 골관절염은 운동선수나 관절을 다치거나 외상을 입은 사람들에게서 많이 발생합니다. 또한, 전 세계 골관절염 환자의 60%가 여성에게 많이 발생하며, 여성은 전 세계 골관절염 환자의 60%를 차지합니다.

세계보건기구(WHO)의 보고에 따르면, 골관절염은 노년층에서 더 많이 발생한다고 합니다. 또한 골관절염은 누구나 걸릴 수 있지만, 40세 이상의 성인에게 가장 많이 나타나는 질환입니다. 또한 WHO의 보고에 따르면 인구의 약 73%가 55세 이상의 노인이며, 그 중 60%가 여성입니다. 미국 질병예방통제센터(CDC)의 보고에 따르면, 미국에서는 3,250만 명 이상의 성인이 OA를 앓고 있습니다. 이처럼 OA의 유병률이 증가함에 따라 생물학적 치료와 같은 새로운 치료법이 전 세계적으로 주목받고 있습니다. 혈소판이 풍부한 혈장(PRP) 요법은 혈소판이 풍부한 혈장(PRP) 요법이 유망한 OA 치료법으로 부상하고 있으며, PRP는 신체의 자연 치유 및 조직 복구 과정을 촉매하여 조직 회복을 촉진합니다.

보고서 구분 및 조사범위 :

골관절염 치료 시장은 치료 유형, 적응증, 최종 사용자로 구분됩니다. 치료 유형에 따라 시장은 경피적 전기신경자극요법(TENS), 작업치료, 물리치료, 다혈소판 혈장(PRP) 치료 및 간질혈관분획술, 프롤로테라피, 기타로 분류됩니다. 질환 적응증별로는 무릎관절증, 척추관절증, 족부관절증, 어깨관절증, 손관절증, 기타로 구분됩니다. 최종 사용자별로는 병원 및 클리닉, 전문 클리닉, 외래수술센터(ASC), 재택치료, 기타로 구분됩니다.

치료 유형별 인사이트

치료 유형별로 골관절염 치료 시장은 경피적 전기신경자극(TENS), 작업치료, 물리치료, 다혈소판 혈장 및 간질혈관 분획, 프롤로테라피, 기타로 분류됩니다. 물리치료 분야는 2022년 골관절염 치료 시장의 치료 유형별 부문에서 가장 큰 시장 점유율을 차지했습니다. 기타 부문은 예측 기간 동안 가장 빠른 CAGR 7.5%로 성장할 것으로 예상되며, 2022년 골관절염 치료 시장에서 물리치료 부문이 치료 유형별 부문에서 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 기타 부문은 예측 기간 동안 가장 빠른 CAGR 7.5%를 나타낼 전망입니다. 요가와 같은 물리치료는 무릎 관절염 환자의 신체 기능을 개선하는 데 도움이 될 수 있습니다. 임상 연구에 따르면 물리치료(PT)를 받는 무릎 골관절염 환자들은 글루코코르티코이드 주사를 맞는 환자들보다 삶의 질(QOL)이 더 높은 것으로 나타났습니다. 또한, 물리치료는 글루코코르티코이드 주사보다 임상적으로 더 효과적이며 비용 효율적인 대안으로 인식되고 있습니다.

골관절염 치료 시장에서 기타 분야가 가장 높은 CAGR을 나타낼 것으로 추정됩니다. 또 다른 치료법은 골관절염에 대한 재활 요법입니다. 재활 프로그램은 통증을 완화하고 기능을 빠르게 개선할 수 있도록 고안된 프로그램입니다. 재활의 주요 목적은 무릎 OA의 증상을 완화하고 진행을 늦추는 것입니다. 미래의 전망과 재활에는 OA의 비약리학 적 관리에 이어 삶의 질, 관절 기능, 근력, 근력, 근력 및 기능적 성능을 효과적으로 개선하는 운동이 포함됩니다. 따라서 재활 프로그램의 수정은 궁극적으로 환자의 골관절염 통증을 줄이고 예측 기간 동안 골관절염 치료 시장의 성장을 강화할 것입니다.

질병 기반 인사이트

무릎 골관절염 부문은 2022년 골관절염 치료제 시장에서 적응증별로 가장 큰 시장 점유율을 차지할 것으로 예상되며, 예측 기간 동안 7.7%의 연평균 복합 성장률(CAGR)로 가장 빠른 성장을 보일 것으로 예상됩니다. 미국 과학 아카데미 보고서에 따르면, 무릎 관절염(KO)은 전체 질병 부담의 80% 이상을 차지하며, 45세 이상 미국 성인의 약 19%가 매년 무릎 관절염을 앓고 있습니다. 제조업체의 혁신적인 제품 출시는 무릎 골관절염의 부담을 줄이는 데 도움이 되며, 2021년 9월 콘투라 인터내셔널(Contura International Ltd)은 무릎 OA로 인한 통증을 완화하는 안전하고 효과적이며, 오래 지속되는 저침습적 치료법에 대한 미충족된 임상적 요구를 충족시킬 수 있는 무릎 OA의 통증을 완화하는 안전하고 효과적이며, 지속적이고 저침습적인 치료제에 대한 미충족된 임상적 니즈를 충족시키는 신제품 'Arthrosamid'의 출시를 발표하였습니다. 따라서 무릎 OA 유병률 증가와 골관절염 통증을 최소화하는 혁신적인 제품 출시가 골관절염 치료제 시장의 성장을 주도하고 있습니다.

최종 사용자 기반 인사이트

2022년 골관절염 치료 시장의 최종 사용자 부문별 시장 점유율은 홈케어 부문이 가장 높을 것으로 예상됩니다. 병원 및 클리닉 부문은 예측 기간 동안 7.5%의 가장 높은 CAGR을 나타낼 것으로 예상됩니다. 관절염을 극복하기 위한 가장 중요한 치료법은 과체중을 줄이는 것입니다. 또한, 온열 및 냉찜질 요법은 경직된 관절에 유연성을 회복하고 관절 통증을 완화하는 데 도움이 될 수 있습니다. 전기 담요나 습식 온열 패드를 사용하면 통증을 완화하는 데 도움이 되는 것으로 입증되었습니다. 그러나 얼음 팩이나 냉동 야채 주머니와 같은 냉찜질 요법을 관절 부위에 적용하면 통증을 완화하는 데 도움이 될 수 있습니다. 이러한 치료 옵션의 가용성은 집에서 골관절염을 관리하는 성공적인 치료법으로 입증되었으며, 이는 홈케어 부문의 골관절염 치료 시장의 성장을 주도하고 있습니다.

지역별 분석 :

지역별로 세계 골관절염 치료제 시장은 북미, 유럽, 아시아태평양, 중남미, 중동 및 아프리카로 구분되며, 2022년 북미는 골관절염 치료제 세계 시장 점유율이 가장 규모가 큰 지역입니다. 아시아태평양은 2022-2030년 가장 높은 CAGR을 나타낼 것으로 예상됩니다. 북미 시장에서는 미국이 골관절염 치료제 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 미국 질병예방통제센터(CDC) 보고서에 따르면, 골관절염(OA)은 가장 흔한 관절염으로 미국 내 3,250만 명의 성인이 앓고 있는 것으로 나타났습니다. 또한 Osteoarthritis(OA) Action Alliance의 보고서에 따르면, 미국 내 OA와 관련된 경제적 부담은 연간 1,368억 달러로 추정됩니다. 또한, 미국 방사선학회(ARRS)의 보고서에 따르면, OA의 평생 위험도는 50%이며, 2040년까지 미국 내 성인의 7,800만 명(26%)이 OA에 걸릴 것으로 추산됩니다.

또한, 골관절염 통증에 대한 비약물 요법을 목표로 하는 제조업체의 신제품 승인은 골관절염 치료 시장의 성장에 영향을 미칠 것입니다.2021년 6월, CyMedica Orthopedics는 무릎 골관절염 통증에 대한 비침습적 치료법인 Intellihab System'의 FDA 승인을 획득했다고 발표했습니다. 이번 신제품 출시는 퇴행성 골관절염 질환을 동반한 OA 통증을 치료하기 위해 고안된 치료적이고 디지털 기반의 에코시스템입니다. 따라서 골관절염 치료에서 약물에 대한 의존도를 낮추기 위한 새로운 비약물 요법은 예측 기간 동안 골관절염 치료 시장의 성장을 가속할 것으로 보입니다.

목차

제1장 서론

제2장 주요 요약

  • 주요 인사이트

제3장 조사 방법

  • 조사 범위
  • 2차 조사
  • 1차 조사

제4장 골관절염 치료 시장 구도

  • PEST 분석
  • 파이프라인 분석
    • 임상시험 파이프라인 분석

제5장 골관절염 치료 시장 - 주요 시장 역학

  • 골관절염 치료 시장 - 주요 시장 역학
  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 동향
  • 성장 촉진요인과 억제요인의 영향

제6장 골관절염 치료 시장 : 세계 시장 분석

  • 골관절염 치료 시장 매출,2022-2030년
    • 골관절염 치료 시장 매출, 2022년-2030년

제7장 골관절염 치료 시장 분석 : 치료 유형별

  • 경피적 전기 신경 자극치료(TENS)
  • 작업치료
  • 물리치료
  • 혈소판 풍부 혈장 요법 및 기질 혈관 분획술
  • 프롤로테라피
  • 기타

제8장 골관절염 치료 시장 분석 : 적응 질환별

  • 변형성 슬관절증
  • 변형성 척추증
  • 변형성 족관절증
  • 어깨 골관절염
  • 손 골관절염
  • 기타

제9장 골관절염 치료 시장 분석 : 최종사용자별

  • 병원 및 진료소
  • 전문 클리닉
  • 외래수술센터(ASC)
  • 재택치료
  • 기타

제10장 골관절염 치료 시장 : 지역별 분석

  • 개요 북미
    • 북미
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 호주
    • 한국
    • APAC 기타 국가
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 기타 중동 및 아프리카
  • 중남미
    • 브라질
    • 아르헨티나
    • 기타 중남미

제11장 업계 상황

  • 골관절염 치료 세계 시장 성장 전략
  • 유기적 개발
  • 무기적 전개

제12장 기업 개요

  • Vision Quest Industries Inc
  • Dr PRP USA LLC
  • Estar Technologies Ltd
  • Zimmer Biomet Holdings Inc
  • DePuy Synthes Inc
  • Bioventus Inc
  • Omron Healthcare Inc
  • Exactech Inc
  • Medi GmbH & Co KG
  • Zealmax Innovations Pvt Ltd

제13장 부록

LSH 24.04.26

The osteoarthritis therapy market size is projected to grow from US$ 17.36 billion in 2022 to US$ 30.68 billion by 2030; the market is estimated to record a CAGR of 7.4% during 2022-2030. The rising prevalence of osteoarthritis and innovative therapy options reducing dependency on medications are the key factors propelling the osteoarthritis therapy market development. However, product recall hamper the osteoarthritis therapy market growth. Furthermore, more effective treatment options to fuel osteoarthritis therapy acts as a lucrative market trend during the forecast period.

Growth Drivers:

Rising Prevalence of Osteoarthritis Drives Osteoarthritis Therapy Market Growth

Globally, OA affects more than 500 million people, accounting for 7% of the world's population, according to the CDC report. It represents a major cause of long-term disability. Osteoarthritis is more prevalent among athletes and people who sustain joint injury or trauma. Moreover, it is more prevalent among women, accounting for 60% of global osteoarthritis cases.

According to the World Health Organization (WHO) report, osteoarthritis is more prevalent among the older population. Also, OA can affect anyone, but the condition is most commonly observed in adults aged 40 years and above. Also, the WHO report further reveals that about 73% of the population is older than 55 years and living with OA, among which 60% are female. According to the Centers for Disease Control and Prevention (CDC) report, over 32.5 million adults in the US are affected by OA. Thus, with the rising prevalence of OA and, new therapy options, such as biological therapy, are gaining attention worldwide. Platelet-rich plasma (PRP) therapy is one example that has emerged as a promising OA treatment. PRP enhances tissue recovery by catalyzing the body's natural healing and tissue repair processes.

Report Segmentation and Scope:

The osteoarthritis therapy market is segmented into therapy type, disease indication, and end user. Based on therapy type, the market is segmented into Transcutaneous Electrical Nerve Stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy and stromal vascular fraction, prolotherapy, and others. The market is segmented by disease indication into knee osteoarthritis, spine osteoarthritis, foot & ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. In terms of end-users, the market is segmented into hospitals & clinics, specialty clinics, ambulatory surgical centers (ASCs), homecare, and others.

Therapy Type-Based Insights

By therapy type, the osteoarthritis therapy market is segmented as transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma and stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share of the osteoarthritis therapy market by therapy type segment in 2022. The others segment is anticipated to grow at the fastest CAGR of 7.5% during the forecast period. The physical therapy segment held the largest market share of the osteoarthritis therapy market by therapy type segment in 2022. The other segment is anticipated to grow at the fastest CAGR of 7.5% during the forecast period. Physical therapies, such as yoga, help improve physical function in patients affected by knee osteoarthritis. The clinical study reveals that the patients suffering from knee osteoarthritis receiving physical therapy (PT) have gained more quality-adjusted life-years than those receiving glucocorticoid injections. Additionally, physical therapy is clinically more effective than glucocorticoid injection; moreover, it is perceived as a more cost-effective option.

The other segment is estimated to register the highest CAGR for the osteoarthritis therapy market. Another therapy is rehabilitation therapy for osteoarthritis. The rehabilitation program is designed to reduce pain and increase functionality quickly. The rehabilitation's main goal is to relieve knee OA symptoms and slow its progression. The future perspective and rehabilitation include nonpharmacological management of OA followed by exercise, which effectively improves the quality of life, joint function, muscle power, strength, and functional performance. Therefore, modifications in rehabilitation programs will ultimately reduce the patients' osteoarthritis pain, bolstering the osteoarthritis therapy market growth during the forecast period.

Disease Based Insights

The knee osteoarthritis segment held the largest market share of the osteoarthritis therapy market by disease indication segment in 2022, and the same segment is anticipated to grow at the fastest CAGR of 7.7% during the forecast period. According to the National Academy of Science report, knee osteoarthritis (KO) accounts for more than 80% of the total disease burden, affecting nearly 19% of American adults aged 45 years and above annually. Launches of innovative products by manufacturers can help reduce the burden of knee osteoarthritis. In September 2021, Contura International Ltd announced a new product launch, "Arthrosamid," an alternative to current therapy that fulfills an unmet clinical need for a safe, effective, long-acting, and minimally invasive treatment for alleviating pain associated with knee OA. Therefore, the rising prevalence of knee OA and innovative product launches to minimize osteoarthritis pain drive the osteoarthritis therapy market growth.

End User-Based Insights

The homecare segment held the largest market share of the osteoarthritis therapy market by end-user segment in 2022. Additionally, the hospitals & clinics segment is estimated to register the highest CAGR of 7.5% during the forecast period. The first and foremost remedy to overcome arthritis is reducing excess body weight. Additionally, hot and cold therapies can bring back flexibility in stiff joints, which can help reduce joint pain. The use of electric blankets or moist heating pads proves helpful in reducing pain. However, cold treatments such as packs of ice or bags of frozen vegetables can be applied to the affected joints, giving relief. Availability of such treatment options proves to be a successful remedy for managing osteoarthritis at home, which drives the osteoarthritis therapy market growth for the homecare segment.

Regional Analysis:

Based on geography, the global osteoarthritis therapy market is segmented into North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa. In 2022, North America held the largest global osteoarthritis therapy market share. Asia Pacific is expected to register the highest CAGR during 2022-2030. In the North American market, the US accounts for the largest market share of the osteoarthritis therapy market. According to the statistics revealed in the Centers for Disease Control and Prevention (CDC) report, osteoarthritis (OA) is the most common form of arthritis, affecting 32.5 million adults in the US. Additionally, the Osteoarthritis (OA) Action Alliance report reveals that the overall economic burden associated with OA in the US is estimated at US$ 136.8 billion annually. Further, the American Roentgen Ray Society ARRS report reveals that the lifetime risk of OA is 50%, and it is estimated that by 2040, ~78 million (26%) adults in the country will have OA.

Further, new product approvals by the manufacturers aiming for non-pharmacology therapy for OA pain influence the osteoarthritis therapy market growth. In June 2021, CyMedica Orthopedics announced receiving FDA approval for the "Intellihab System," a noninvasive modality for knee osteoarthritis pain. The new product launch is a therapeutic and digital-based ecosystem that is designed to treat OA pain with a debilitating osteoarthritis disease. Therefore, new non-pharmacology therapy intended to reduce dependency on therapeutics in OA treatment would fuel the growth of the osteoarthritis therapy market during the forecast period.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

  • 4.1 PEST Analysis
  • 4.2 Pipeline Analysis
    • 4.2.1 Clinical Trial Pipeline Analysis

5. Osteoarthritis Therapy Market - Key Market Dynamics

  • 5.1 Osteoarthritis Therapy Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Osteoarthritis
    • 5.2.2 Innovative Therapy Options Reducing Dependency on Medications
  • 5.3 Market Restraints
    • 5.3.1 Product Recall
  • 5.4 Market Opportunities
    • 5.4.1 Availability of Regenerative Medicine
  • 5.5 Future Trends
    • 5.5.1 More Effective Treatment Options
  • 5.6 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - Global Market Analysis

  • 6.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2022-2030
    • 6.1.1 Overview
    • 6.1.2 Osteoarthritis Therapy Market Revenue (US$ Million), 2022-2030

7. Osteoarthritis Therapy Market Analysis - by Therapy Type

  • 7.1 Overview
  • 7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
    • 7.2.1 Overview
    • 7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Occupational Therapy
    • 7.3.1 Overview
    • 7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Physical Therapy
    • 7.4.1 Overview
    • 7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
    • 7.5.1 Overview
    • 7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Prolotherapy
    • 7.6.1 Overview
    • 7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Osteoarthritis Therapy Market Analysis - by Disease Indication

  • 8.1 Overview
  • 8.2 Knee Osteoarthritis
    • 8.2.1 Overview
    • 8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Spine Osteoarthritis
    • 8.3.1 Overview
    • 8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Foot and Ankle Osteoarthritis
    • 8.4.1 Overview
    • 8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Shoulder Osteoarthritis
    • 8.5.1 Overview
    • 8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Hand Osteoarthritis
    • 8.6.1 Overview
    • 8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Osteoarthritis Therapy Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Hospitals and Clinics
    • 9.2.1 Overview
    • 9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Specialty Clinics
    • 9.3.1 Overview
    • 9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Ambulatory Surgical Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Homecare
    • 9.5.1 Overview
    • 9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. Osteoarthritis Therapy Market - Geographical Analysis

  • 10.1 Overview North America
    • 10.1.1 North America Osteoarthritis Therapy Market Overview
    • 10.1.2 North America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.2.1 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
      • 10.1.2.2 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
      • 10.1.2.3 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
    • 10.1.3 North America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
      • 10.1.3.1 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.3.1.1 Overview
        • 10.1.3.1.2 United States: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.3.1.3 United States: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.3.1.4 United States: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.3.1.5 United States: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.3.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.3.2.1 Overview
        • 10.1.3.2.2 Canada: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.3.2.3 Canada: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.3.2.4 Canada: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.3.2.5 Canada: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.3.3 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.3.3.1 Overview
        • 10.1.3.3.2 Mexico: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.3.3.3 Mexico: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.3.3.4 Mexico: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.3.3.5 Mexico: Osteoarthritis Therapy Market Breakdown, by End User
  • 10.2 Europe
    • 10.2.1 Europe Osteoarthritis Therapy Market Overview
    • 10.2.2 Europe: Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)
      • 10.2.2.1 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
      • 10.2.2.2 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
      • 10.2.2.3 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
    • 10.2.3 Europe: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
      • 10.2.3.1 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.1.1 Overview
        • 10.2.3.1.2 United Kingdom: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.1.3 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.2.3.1.4 United Kingdom: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.2.3.1.5 United Kingdom: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.2.3.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.2.1 Overview
        • 10.2.3.2.2 Germany: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.2.3 Germany: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.2.3.2.4 Germany: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.2.3.2.5 Germany: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.2.3.3 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.3.1 Overview
        • 10.2.3.3.2 France: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.3.3 France: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.2.3.3.4 France: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.2.3.3.5 France: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.2.3.4 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.4.1 Overview
        • 10.2.3.4.2 Italy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.4.3 Italy: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.2.3.4.4 Italy: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.2.3.4.5 Italy: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.2.3.5 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.5.1 Overview
        • 10.2.3.5.2 Spain: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.5.3 Spain: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.2.3.5.4 Spain: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.2.3.5.5 Spain: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.2.3.6 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.6.1 Overview
        • 10.2.3.6.2 Rest of Europe: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.2.3.6.3 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.2.3.6.4 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.2.3.6.5 Rest of Europe: Osteoarthritis Therapy Market Breakdown, by End User
  • 10.3 Asia Pacific
    • 10.3.1 Asia Pacific Osteoarthritis Therapy Market Overview
    • 10.3.2 Asia Pacific: Osteoarthritis Therapy Market
      • 10.3.2.1 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
      • 10.3.2.2 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
      • 10.3.2.3 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
    • 10.3.3 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
      • 10.3.3.1 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.1.1 Overview
        • 10.3.3.1.2 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.1.3 China: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.3.3.1.4 China: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.3.3.1.5 China: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.3.3.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.2.1 Overview
        • 10.3.3.2.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.2.3 Japan: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.3.3.2.4 Japan: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.3.3.2.5 Japan: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.3.3.3 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.3.1 Overview
        • 10.3.3.3.2 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.3.3 India: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.3.3.3.4 India: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.3.3.3.5 India: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.3.3.4 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.4.1 Overview
        • 10.3.3.4.2 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.4.3 Australia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.3.3.4.4 Australia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.3.3.4.5 Australia: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.3.3.5 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.5.1 Overview
        • 10.3.3.5.2 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.5.3 South Korea: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.3.3.5.4 South Korea: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.3.3.5.5 South Korea: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.3.3.6 Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.6.1 Overview
        • 10.3.3.6.2 Rest of APAC: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.3.3.6.3 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.3.3.6.4 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.3.3.6.5 Rest of APAC: Osteoarthritis Therapy Market Breakdown, by End User
  • 10.4 Middle East and Africa
    • 10.4.1 Middle East and Africa Osteoarthritis Therapy Market Overview
    • 10.4.2 Middle East and Africa: Osteoarthritis Therapy Market
      • 10.4.2.1 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
      • 10.4.2.2 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
      • 10.4.2.3 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
    • 10.4.3 Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
      • 10.4.3.1 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.1.1 Overview
        • 10.4.3.1.2 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.1.3 South Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.4.3.1.4 South Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.4.3.1.5 South Africa: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.4.3.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.2.1 Overview
        • 10.4.3.2.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.2.3 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.4.3.2.4 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.4.3.2.5 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.4.3.3 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.3.1 Overview
        • 10.4.3.3.2 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.3.3 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.4.3.3.4 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.4.3.3.5 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.4.3.4 Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.4.1 Overview
        • 10.4.3.4.2 Rest of Middle East and Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.4.3.4.3 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.4.3.4.4 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.4.3.4.5 Rest of Middle East and Africa: Osteoarthritis Therapy Market Breakdown, by End User
  • 10.5 South and Central America
    • 10.5.1 South and Central America Osteoarthritis Therapy Market Overview
    • 10.5.2 South and Central America: Osteoarthritis Therapy Market
      • 10.5.2.1 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Therapy Type
      • 10.5.2.2 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Disease Indication
      • 10.5.2.3 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by End User
    • 10.5.3 South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
      • 10.5.3.1 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.1.1 Overview
        • 10.5.3.1.2 Brazil: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.1.3 Brazil: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.5.3.1.4 Brazil: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.5.3.1.5 Brazil: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.5.3.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.2.1 Overview
        • 10.5.3.2.2 Argentina: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.2.3 Argentina: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.5.3.2.4 Argentina: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.5.3.2.5 Argentina: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.5.3.3 Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.3.1 Overview
        • 10.5.3.3.2 Rest of South and Central America: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.5.3.3.3 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.5.3.3.4 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.5.3.3.5 Rest of South and Central America: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Global Osteoarthritis Therapy Market
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.1 Inorganic Developments
    • 11.1.1 Overview

12. Company Profiles

  • 12.1 Vision Quest Industries Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Dr PRP USA LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Estar Technologies Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Zimmer Biomet Holdings Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 DePuy Synthes Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Bioventus Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Omron Healthcare Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Exactech Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Medi GmbH & Co KG
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Zealmax Innovations Pvt Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제